ESR1 and breast carcinoma: Increased ARTN expression in mammary carcinoma promotes metastasis [8], radio-resistance (manuscript submitted), chemo-resistance [9], endocrine resistance [10] and also enhances CSC like activity in estrogen receptor negative mammary carcinoma (ER-MC) (manuscript submitted).